Josh Bell
Divisional Vice President, Life Sciences Tempus
Seminars
Wednesday 22nd July 2026
Next-Generation Liquid Biopsy: Maximizing Clinical Insights with Tempus xF+
10:00 am
- Learn about the enhanced 523-gene assay, engineered for expanded mutation detection and efficient turnaround times.
- Discover how the panel is designed to help track real-time resistance and catch subclonal escape mechanisms.
- Gain insights into efficiently utilizing Tempus xF+ sequencing data within the Tempus data ecosystem.
